GlobeNewswire

Verno Capital and SPRING merge to create Russian investment management specialist

Del

MOSCOW, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Verno Capital and SPRING, two leading fund managers that specialise in the Russian and CIS markets, today announce plans to merge their public asset management businesses to create a $500 million investment management firm focused on Russia and the CIS region. The terms of the transaction are not being disclosed.

The merged company, Spring Capital, will focus on managing international institutional funds into the public equity markets of the region. The merger will enhance the scale and resources of the combined business, increase operational efficiencies and allow the joint investment team to focus on its core mission of effectively investing on behalf of clients. The private equity businesses of both firms will remain separate.

Verno and SPRING are highly complementary in terms of both expertise and approach. Both firms employ a fundamental, bottom-up investment process and prioritise on-the-ground research and interaction with the companies they invest in. And both firms have deep experience in, and commitment to, the Russian and CIS markets, while operating to best Western business standards.

SPRING, or Specialised Research and Investment Group, was founded in 2003 by Chief Investment Officer David Herne. Herne, who has been based in Moscow since 1992, is well known as one of the most successful and experienced investors in the Russian market. In July, the Financial Times recognised SPRING’s flagship Specialised Russian Growth fund as the No.1 performing Europe-based fund of $100m or more over the previous three years.

Verno Capital was founded in 2009 and has a reputation as the investment manager of choice for major institutions from Europe, the United States and the Middle East seeking exposure to Russia and the CIS. The firm’s public markets business seeks to maximise long-term returns by fundamental stock selection.

Upon completion of the merger, David Herne will be CIO of the new company across the public funds, and the two research teams will be merged. Verno’s Roland Nash will be Chief Investment Strategist and Roman Kudryashov will remain in charge of Verno’s private equity business.

David Herne said: “I look forward to working with Roland and the Verno team. I have enjoyed the past 15 years working with talented, energetic and intellectually curious colleagues and the Verno folks are in the same mould. Our emphasis will remain providing outperformance for our investors in a robust, institutional framework.”

Roland Nash said: “The combination of our businesses creates a formidable player in public equities asset management. Verno and Spring share the same dedication to bringing the best global standards to managing funds in Russia and the CIS region. With this merger, we are able to bring together in one team some of the best and most experienced research and investment professionals in our geography.”

About Verno Capital

Verno Capital is dedicated to investing in the combined Russian and CIS region. Founded in 2009 by one of the leading and most experienced teams in the capital markets of Russia and the former Soviet Union, the firm's objective is to maximise long term returns through on-the-ground research and fundamental bottom-up analysis while managing risks. Verno's investment processes and operational infrastructure are designed to meet the requirements of global institutional investors. 

Verno Capital offers access to investment opportunities both through actively managed public equity funds and through private equity funds in Russia and Kazakhstan. Verno's offices are located in Moscow, London, Astana and Abu Dhabi. Verno is regulated by the FCA in the UK and by the ADGM in Abu Dhabi. 

About SPRING

Founded in 2003, SPRING, Specialised Research and Investment Group, concentrates on managing funds in Russia and the CIS region for international institutional clients. SPRING has offices in London (FCA-regulated), Moscow and the Cayman Islands. The SPRING team has held together through financial crises and market turmoil, outperforming the market through a consistent, research-focused investment process. The team believes that a geographical focus, deep understanding of investee companies and frequent meetings lead to outperformance over the course of the business cycle. The firm employs 20 investment professionals, some of whom have been active in Russia’s financial markets since the 1990’s, when the markets began. They were directly involved in organising such events as the first Russian listing on NYSE (1996), first local IPO (2002) and Russia’s first investor conference (1996). SPRING’s flagship strategy is a Long-Only equity product focused on Russia.

Media Contact:          

Quinn Martin
+1 646 629 5502
quinn@frontierpr.com

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Industry-leaders join BIOPAC for T4 Human Physiology Conference Set for August 12-14, 201919.12.2018 01:34Pressemelding

Training and Best Practices for Measuring Physiology GOLETA, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) -- BIOPAC Systems, Inc., announced the second biennial T4 Human Physiology Conference to be held August 12-14, 2019 at the University of California Santa Barbara (UCSB). Life science researchers, educators, and students are invited to learn the latest Tools, Trends, Techniques, and Technology used in physiological measurement and interpretation. T4 sessions offer hands-on, practical tips and tricks, giving participants the latest tools and insights to pursue scientific discovery with significant amounts of data from multiple participants and devices, in or out of the lab. BIOPAC hosts the T4 Physiology Conference to increase understanding of physiological measurements. Frazer Findlay, BIOPAC CEO, says, “BIOPAC has always placed a strong emphasis on working with partners that understand the industry and the needs of our customers. I am delighted that we’ll have partners joining us at T4 t

RCI Banque S.A.: Post Stabilisation Notice18.12.2018 15:55Pressemelding

PARIS, Dec. 18, 2018 (GLOBE NEWSWIRE) -- 18th December 2018 RCI Banque S.A. Post Stabilisation Notice HSBC (contact: Syndicate desk, telephone: +44 207 992 8066) hereby gives notice that no stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken in relation to RCI Banque S.A. GBP Fixed due 30th Oct 2023 because the transaction did not complete. Issuer: RCI Banque S.A. Guarantor (if any): NA Aggregate nominal amount: GBP Benchmark Description: Fixed due 30th Oct 2023 Offer price: na Stabilising Managers: HSBC, Lloyds, Natwest This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and condit

The North American Bitcoin Conference Stands Out as One of 2019’s Most Important Worldwide Crypto Events18.12.2018 15:35Pressemelding

MIAMI, Dec. 18, 2018 (GLOBE NEWSWIRE) -- via CryptoCurrencyWire – 2019 will kick off with what has become widely accepted as one of the most important blockchain conferences of the year. The North American Bitcoin Conference, sponsored by Keynote and part of the World Blockchain Forum, will take place Jan. 16-18, 2019, at the James L. Knight Center in Miami, Florida. This premier crypto conference, now in its seventh year, will draw cryptocurrency and blockchain leaders from all across the globe as they come together for this historical event. The North American Bitcoin Conference is the longest-running, most-attended finance conference for the blockchain and crypto industries, with each event attracting thousands of attendees. The 2019 conference will feature a lineup of more than 60 world-class presenters, including technology veterans and company founders who have collectively raised more than $18.1 billion in initial coin offerings (ICOs). Speakers that have been announced thus far

Inspirata Subsidiary, Artificial Intelligence in Medicine (AIM), Signs Contract with the National Cancer Institute (NCI) to Use Its E-Path Reporter Software for Reporting by U.S. Central Cancer Registries18.12.2018 15:06Pressemelding

The NCI has licensed AIM’s E-Path Reporter software for the last 15 years to provide an automated solution that enables cancer registries to more efficiently collect and report cancer incidence and survival data. Toronto, CA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Artificial Intelligence In Medicine Inc. (AIM), an Inspirata company, announced today that the National Cancer Institute (NCI) has extended its license agreement for AIM’s E-Path Reporter software. The software has been licensed for use within the SEER (Surveillance, Epidemiology and End Results) program, for 14 central registries and 286 major reporting hospitals and laboratories across the U.S. NCI supports cancer data collection and research through the SEER program and publishes cancer statistics for 20 U.S. geographic areas. The NCI requires participating cancer registries to collect data on cancer patient demographics, primary tumor site, tumor morphology and disease stage at diagnosis. The registries also must report on fir

Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services18.12.2018 14:30Pressemelding

Services and Capacity Increase with New Site Opening SAN DIEGO, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has recently announced the expansion of its existing translational oncology research capacity by opening a new site in Suzhou, Jiangsu, China. The large amount of data now available from preclinical and clinical research requires specialized expertise in bioinformatics, big data analysis and dedicated storage facilities. CrownBio’s new site will focus on integrating the company’s experience in preclinical and translational research with cutting-edge digital technologies for the discovery of predictive biomarkers and the development of new and companion diagnostics. The Suzhou site will become CrownBio’s center of excellence for systems biology and clinical sample testing. Located at the heart of the Bi

Family of Constant-Current Dimmable Buck LED Drivers18.12.2018 11:00Pressemelding

1.5A, 3A Buck LED Drivers Target ISO26262 automotive and industrial applications MILPITAS, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) -- AMS, the Analog Mixed-Signal division of ISSI, has introduced a family of switching buck LED Drivers for automotive and industrial applications. This family of highly integrated switching constant current buck LED Drivers are targeted for 12V/24V battery connected, space-constrained, electromagnetic (EMC) sensitive applications such as Headlight, Front and Rear Fog lights, Day time Running lights to name a few. The device family supports a wide DC voltage input range of 4.5V to 38V and outputs a 5% regulated current of 1.5A or 3A; depending on the particular device, see table. The integrated power MOSFET is configured to switch in the constant on-time mode delivering true average current. Switching at a frequency of up to 2MHz which is adjustable with an external resistor, these buck LED Drivers can use smaller output inductor and capacitor values thereby